Federico Grossi
Director/Board Member chez Endoprotech, Inc.
Fortune : 6 M $ au 31/03/2024
Profil
Federico Grossi occupe le poste de médecin en chef chez Apellis Pharmaceuticals, Inc. Il est également membre du conseil d'administration d'Endoprotech, Inc. Dans le passé, le Dr Grossi a été directeur de la recherche clinique chez Potentia Pharmaceuticals, Inc. et vice-président exécutif de Potentia Pharmaceuticals, Inc. et membre de l'équipe de transplantation de l'Université de Louisville. Il a obtenu un diplôme d'études supérieures et un doctorat de l'Université de Louisville et un doctorat de l'Université nationale de Cordoba.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/01/2023 | 94 884 ( 0,08% ) | 6 M $ | 31/03/2024 |
Postes actifs de Federico Grossi
| Sociétés | Poste | Début |
|---|---|---|
Endoprotech, Inc.
 Endoprotech, Inc. Medical DistributorsDistribution Services Endoprotech, Inc. develops therapies for organ transplantation and invasive cardiovascular surgery. The company was founded on August 17, 2005 and is headquartered in Louisville, KY. | Director/Board Member | - |
Anciens postes connus de Federico Grossi
| Sociétés | Poste | Fin |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 03/01/2023 |
Potentia Pharmaceuticals, Inc.
 Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Corporate Officer/Principal | 01/09/2014 |
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Chief Tech/Sci/R&D Officer | 01/04/2010 |
| University of Louisville | Corporate Officer/Principal | - |
Formation de Federico Grossi
| University of Louisville | Doctorate Degree |
| National University of Cordoba | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Health Technology |
Endoprotech, Inc.
Endoprotech, Inc. Medical DistributorsDistribution Services Endoprotech, Inc. develops therapies for organ transplantation and invasive cardiovascular surgery. The company was founded on August 17, 2005 and is headquartered in Louisville, KY. | Distribution Services |
